An anti-poverty advocacy group has flagged COVID-19 vaccine stockpiling by high-income countries in a new report.
An analysis by the ONE Campaign, a movement which seeks to end poverty and preventable disease by 2030, said a cohort of wealthy nations had stockpiled more than a billion COVID-19 vaccine doses than required. Raporda, önde gelen beş COVID-19 aşısı üreticisi olan AstraZeneca ve Oxford Üniversitesi, Johnson & Johnson, Moderna, Novavax ve Pfizer ve BioNTech ile yapılan sözleşmeler incelendi. Avustralya, Kanada, Avrupa Birliği, Japonya, Birleşik Krallık ve Amerika Birleşik Devletleri'nin, nüfuslarını tam olarak aşılamak için yalnızca 2.06 milyara ihtiyaç duymalarına rağmen, üç milyardan fazla aşı dozunu güvence altına aldıklarını buldu.
ONE Campaign'in kıdemli politika müdürü Jenny Ottenhoff'a göre raporun bulguları, "büyük aşırılığı" ve "aşı milliyetçiliğinin somutlaşmış halini" temsil ediyor. Ottenhoff, "Zengin ülkelerin salgının başlarında aşılarla ilgili bahislerini anlaşılır bir şekilde korumaya aldıklarını, ancak bu bahislerin fazlasıyla karşılığını almasıyla birlikte, dünya çapında milyarlarca insanı koruyacaksak büyük bir rota düzeltmesi gerektiğini" kabul etti.
Vaccine nationalism engendering vaccine stockpiling has been called out repeatedly in recent months, as the global race to develop vaccines against the novel coronavirus which causes COVID-19 has yielded results and countries – Hindistan dahil – have commenced campaigns to inoculate their populations. However, there are striking global disparities in access to COVID-19 vaccines at the detriment of countries at lower levels of economic development.
Daha önce bu hafta, Birleşmiş Milletler Genel Sekreteri António Guterres bunu kınadı “progress on vaccinations has been wildly uneven and unfair. Just ten countries have administered 75 percent of all COVID-19 vaccines. Meanwhile, more than 130 countries have not received a single dose. Those affected by conflict and insecurity are at particular risk of being left behind.”
Guterres'in sözlerinden önce, the incoming World Trade Organization chief Ngozi Okonjo-Iweala highlighted that “no one is safe until everyone is safe. Vaccine nationalism at this time just will not pay, because the variants are coming. If other countries are not immunised, it will just be a blow back.”
The COVAX facility, designed to ensure access to COVID-19 vaccines for low- and middle-income nations, has inked deals to procure 2.27 billion doses this year and aims to deliver doses to at least twenty percent of the populations of the world’s most impoverished countries. India is a key player, being home to the Serum Institute of India – the world’s largest manufacturer of vaccines. India’s seeming embrace of vaccine diplomacy is manifest in recent developments which have witnessed large-scale distribution to other countries. Tarafından bildirildiği gibi Sağlık Sorunları Hindistan bu hafta başında
“Geçen ay ülke COVID-19 aşılarının ihracatına başladı. Şubat ayının ikinci haftası itibarıyla ülke, yüzde 1.6'si hibe olmak üzere yirmi ülkeye 37'dan fazla crore aşı dozu ihraç etti. Yurt dışına gönderilen dozların kalan yüzde 63'ü satışlardı. Hindistan'dan aşı ihracatı alan ülkeler arasında Afganistan, Cezayir, Bahreyn, Bangladeş, Barbados, Butan, Brezilya, Dominika, Mısır, Kuveyt, Maldivler, Mauritius, Fas, Myanmar, Nepal, Umman, Seyşeller, Sri Lanka, Güney Afrika, ve Birleşik Arap Emirlikleri. "
Vaccine stockpiling engendering a surplus in wealthy nations could fortify COVAX initiatives if surplus vaccines are donated, the ONE Campaign report suggests. Countries including France and the United Kingdom are onboard with such a notion. French president Emmanuel Macron proposed wealthier countries dedicate up to five percent of their vaccine reserves to Africa, where vaccine supplies are lacking. İngiliz başbakanı Boris Johnson is expected to pledge donations of the UK’s surplus vaccine supply to low-income nations at today’s G7 summit. COVAX is also the beneficiary of a US$4 billion donation from the U.S. government. Ultimately, we are not safe until we are all safe. COVID-19 does not discriminate and does not respect borders. As such, when it comes to protection via vaccination, universalism and by extension cooperation is the need of the hour.
İlgili bağlantılar
Source: https://www.healthissuesindia.com/2021/02/19/vaccine-stockpiling-flagged-by-group/